Candidate: Anti-SARS-CoV-2 monoclonal antibodies for the treatment of COVID-19 Types: Fully human monoclonal antibodies targeting immutable sites confirmed as 98.71% to 99.29% conserved over the entirety of […]
-
Enzolytics
Read more »Candidate: Anti-SARS-CoV-2 monoclonal antibodies for the treatment of COVID-19 Types: Fully human monoclonal antibodies targeting immutable sites confirmed as 98.71% to 99.29% conserved over the entirety of all 1 million coronavirus isolates. […]
-
COVID-19 Case Estimations From SARS-CoV-2 Genome Mutations
Read more »A new study published in Nature Communications reconstructs regional incidence profiles of COVID-19, highlighting the effects of non-pharmaceutical interventions (NPI) and different testing strategies. Daily counts of new COVID-19 cases remain a basis […]
-
Cross-Protective COVID Immunity: One Coronavirus Vaccine Can Provide Broad Immunity Against Other Coronaviruses
Read more »Study is the first to demonstrate cross-protective immunity by vaccines. Northwestern Medicine scientists have shown for the first time that coronavirus vaccines and prior coronavirus infections can provide broad immunity […]
-
Immune Responses From 3 Different COVID-19 Vaccines Compared Over 8 Months
Read more »Strong antibody response to mRNA vaccines declined over an eight-month follow-up period; lower initial response to single-shot Ad26 vaccine remained stable over time, research shows. Based on the strength of […]
-
Research Shows High Effectiveness of Mix-and-Match COVID-19 Vaccines
Read more »People who had received a first dose of the Oxford-AstraZeneca COVID-19 vaccine and received an mRNA vaccine for their second dose had a lower risk of infection compared to people who had […]
Enzolytics
Candidate: Anti-SARS-CoV-2 monoclonal antibodies for the treatment of COVID-19 Types: Fully human monoclonal antibodies targeting immutable sites confirmed as 98.71% to 99.29% conserved over the entirety of […]
COVID-19 Case Estimations From SARS-CoV-2 Genome Mutations
A new study published in Nature Communications reconstructs regional incidence profiles of COVID-19, highlighting the effects of non-pharmaceutical interventions (NPI) and different testing strategies. Daily counts of new […]
Cross-Protective COVID Immunity: One Coronavirus Vaccine Can Provide Broad Immunity Against Other Coronaviruses
Study is the first to demonstrate cross-protective immunity by vaccines. Northwestern Medicine scientists have shown for the first time that coronavirus vaccines and prior coronavirus […]
Immune Responses From 3 Different COVID-19 Vaccines Compared Over 8 Months
Strong antibody response to mRNA vaccines declined over an eight-month follow-up period; lower initial response to single-shot Ad26 vaccine remained stable over time, research shows. […]
Research Shows High Effectiveness of Mix-and-Match COVID-19 Vaccines
People who had received a first dose of the Oxford-AstraZeneca COVID-19 vaccine and received an mRNA vaccine for their second dose had a lower risk of infection […]
Clinical Trial Has Found Interferon Does Not Help Adults Hospitalized With COVID-19
A clinical trial has found that treatment with the immunomodulator interferon beta-1a plus the antiviral remdesivir was not superior to treatment with remdesivir alone in […]
Valneva reports positive results from vaccine trial
Valneva vaccine shows good outcomes in comparison with AstraZeneca jab A covid-19 vaccine made by Valneva produced stronger antibody responses and fewer side effects than […]
Scientists develop new strategy that rapidly quantifies transmissibility of COVID-19 variants
A team of researchers has developed a new nanomechanical technique for fast, one-step, immune-affinity tests, which can quantify the immune response induced by different COVID-19 […]
COVID-19-related parenting stress impacted eating habits of children
The incredible stress parents experienced during the COVID-19 pandemic had a negative effect on the eating habits of their children, according to a new study […]
COVID Patients With High BMI Face Longer ICU Stay and Increased Risk of Death
High BMI independently associated with death and longer ICU stay for COVID patients. Obese patients (BMI >35 kg/m2) were twice as likely to experience a […]